EuroQuity Blog
News

We are very pleased to announce you the fourth e-pitch session we are organising in collaboration with Solar Impulse Foundation on September 8th at 17:00 CEST.


JOIN THE SOLAR IMPULSE E-PITCH SESSION ON SEPTEMBER 8TH AT 5:00PM CET
The fourth E-pitch exclusively for Solar Impulse Labelled Solutions.
Witness 6 of the finest startups pitching to you directly online.
You can register by clicking here.

Here is the selection:
 

TURKEY - Cleantech / Energy – Biogas & Organic Fertilizer from Paper Mill Sludge

The start-up has developed a paper production waste disposal technology, which enables the use of paper mill sludge in biogas/renewable energy and organic fertilizer production. Our technology is used in pretreatment of paper mill sludge and making it ideal for the biogas process. It helps companies to reduce their carbon footprint. The solution has already been successfully tested with the largest paper producer in Turkey.

10+ patents worldwide; First contract | TRL: 7 | TAM: €1.5bn/year | Next Step: Construction of first commercial plant | Amount to raise: €8.5M
 

GERMANY – Cleantech / Circular Economy – B2B marketplace for circular plastics

Born out of the Entrepreneur First Ltd (UK) talent investment program, the start-up is developing a global marketplace for recyclates and plastic waste feedstock on the backheels of sweeping new regulations (e.g. EU Plastic Tax) forcing brand owners to use more recycled plastic in all of their products. It connects the plastics value chain from end-to-end starting. By integrating logistics, testing, trade finance, credit insurance and certification, the start-up significantly lowers the transaction costs for recyclates and leverages AI to create a solid business case for the plastic industry to become more sustainable.

Launched on March 2nd |390 active companies from 49 countries – GMV (Gross Merchandise Value) on August 1st: €412 |TRL: 7 | €34bn |Next step: logistics integration | Amount to raise: €2m


FINLAND - Carbon removal / Circular Economy - High purity, conductive, functional biocarbons from waste
Commercialising a breakthrough technology in the carbon conversion domain. The patented technology has the ability to process a multitude of biomass waste in a semi-modular facility designed to be rapidly deployable on site. The resulting biocarbons are remarkably stable, high in fixed carbon and conductive, which is increasingly understood as a potential key to bacterial processes. They have €1m+ in LOIs and they are focusing on pre-sales now with still limited production capacity, as the team looks to scale up the production in 2020-2021 to meet growing demand from environmental remediation (water, soil, toxins) and novel materials.
TRL: 6 | TAM: €10+ bn | Next step: Building a deep demonstration of the technology and entering large scale pilots with customers  | Raising: €2-5m
 

FRANCE – Cleantech – The first substitute for gold

Spin-off from a French laboratory of excellence, the start-up has developed innovative materials and processes, which can both reduce gold consumption and open up new ways of using gold. The solution decreases the environmental impact of gold mining and is an alternative to the rising price of gold. The technology has firstly been successfully deployed on high end luxury and the start-up works now to implement it on the broader jewelry market. In the long term, this technology conceals other development opportunities in high value-added markets such as the biomedical and chemical industries.

4 granted patents worldwide; 15 paying customers | TRL: 8 | TAM: €20bn | Next step: industrialization | Amount to raise: €1m
 

FRANCE – Greentech / Cleantech – Recycling of plastic nets with an eco-friendly process
The start-up has developed a technology that allows the dry cleaning and recycling of plastic nets and fibers. The technology is patented and certified by an ETV (Environmental Technology Verification). The pilot made it possible to produce the world's first agricultural nets from recycled material in closed loop. The start-up has secured its upstream supplies and has pre-sales agreements for its PCR (Post-Consumer Recycling Resin).
Unique recycling solution worldwide – 1.75tCO² saved per ton of plastic | TRL: 7-8 | TAM (total addressable market): €1.95bn | Next Step: industrialization | Amount to raise: €4m

MEXICO - BioFabricated Materials - BioFabricated Leather-like material
We are creating leather from agroindustrial food-waste in one of Mexico's most important industrial corridors. This BioFabrictaed leather-like material is Animal Free and Plastic Free. Our solution has been awarded by MIT, Mass Challenge, Dow Chemical Company and INCMty. We have successfully launched a pilot plant and are negotiating agreements with international luxury, apparel and shoe brands. We are finalizing our Seed Round to scale our operation into a 15,000 sq.ft industrial facility that will allow us to deliver the first batches of the material.
3+ patents; 3 more to come by late 2020. 14 LOI´s from Luxury, Apparel, Shoe and Automotive Companies. | TRL: 6-7 | TAM: €45bn | Next Step: industrialization | Amount to raise: €3.5m



Wednesday, September 2nd 2020
BlueInvest and EIPP join forces and will be introducing green shipping and ocean clean-up solutions next 15th of July at 3:00 PM CEST
BlueInvest and the European Investment Project Portal (EIPP) are delighted to present the second edition of the BlueInvest e-pitch session, which will be held online on Wed 15 July at 3:00 PM CET. If you are interested but not available, you are welcome to register to have access to the recorded session.

This session features European companies with innovative and sustainable technologies for ports, green shipping and ocean clean-up.

BlueInvest  is an EU initiative to boost innovation and investment in sustainable technologies for the blue economy, by supporting readiness and access to finance for early-stage businesses, SMEs and scale-ups. It is enabled by the European Maritime and Fisheries Fund.

The European Investment Project Portal  is an EU matchmaking portal, enabling EU-based project promoters – public or private – to reach potential investors worldwide. It is a free service offered by the European Commission and is part of the Investment Plan for Europe, which aims to mobilise investment, boost economic growth and create jobs across the EU.
We hope to see you on Wed 15 July, 3:00 PM CET.
 
If you have any questions, please contact Cristina Chumacero .

Ocean clean-up
A solution for two huge problems regarding the marine environment: excess of water recovered during Oil Spill Recovery Operations and recovery of micro-plastics. This innovative project is based on a patented device that will be an essential tool to protect the marine environment and to promote the blue economy. This project will address a business opportunity related to the reduction of seaport management costs by reducing drastically the amount of water recovered by the existing oil recovery machinery, improvement of the marine activities and removal of tiny plastic debris that are being eaten by fish and consequently by humans. Recipient of the EC Seal of Excellence. Market classification: Pre-commercial, construction started | Next step: Commercialisation | € 1.7m sought – Spain
 
Green shipping
Autonomous navigation powered by artificial intelligence considering real time maritime traffic and weather conditions. We have developed an artificial intelligence that combines Copernicus data and maritime traffic conditions to optimise the journey of ships, saving them time and fuel on local and international routes. This solution can be offered to all kinds of fleet operators shipping cargo, including tankers, consumer goods, plus fishing fleets, ferries, and cruise liners and also small maritime operators and sailors. A revolutionary technology selected by the European Space Agency. Market classification: Prototype, pre-commercial | Next step: Commercialisation | € 1.3m sought – Germany
 

Green shipping
This modular electro-chlorination Ballast Water Management System provides a unique and safe solution giving greater flexibility on installation, overall reduced costs and energy consumption. A combination of two methods of treatment is used, giving optimum results in a marine environment. Both Solutions meet current and future legislation in our changing world. The first by using a low energy frequency Sea Water Conditioning Unit on the main ballast water fill line eliminating the need for filtration. The second through the production of concentrated sodium hypochlorite from seawater using a high capacity electro-activation cell.
Market classification: Mature, ready for commercialisation | Next step: Commercialisation | € 7.5m sought – Cyprus 
 
Green construction for marine environments
High-performance building material that will be one of the first of the Carbo-Negative materials capable of replacing cement, concrete, steel, wood and aluminium. Its carbon footprint is 90% smaller than cement, steel, aluminum and many other materials in virtually all forms of building and infrastructure projects. Manufacturing for this versatile, revolutionary material is CO2-free. Material is corrosion-free and will cut installation times by a factor of 2 or more. Applications include granite that bends, railway sleepers that outlast testing equipment, marine vessels that won’t rust, roofs, domes, dams, bridges and ports with biblical longevity.
Market classification: Prototype, pre-commercial | Next step: Commercialisation | € 7-15m sought – France
 
Ocean waste management
Plastic Cleanup System designed to be easily replicated to be suitable for scalability. The package currently includes an Impact Picture the helps the contributor envision the impact that is created via the ocean-bound plastic waste collection where most of his/her purchase is channeled. The contributor receives a Process Picture for envisioning the process how plastic is collected and recycled to have a better overview of the actual collection activity.
Market classification: Pre-commercial | Next step: Commercialisation | € 0.25m sought – Hungary
 
River clean-up
The most effective and affordable River Plastic Interception technology. 100% Collection effectiveness, 20% ROI.
Market classification: Commercial | Between EUR 0.5m-3m sought – UK


You can register here: https://forms.gle/Wv7GwhJTmfzzJujd8   


Tuesday, July 7th 2020
We’ve got some exciting news… We are proud to introduce you the Polish Agency for Enterprise Development (PARP) on EuroQuity!
Polish Agency for Enterprise Development is a governmental body whose objective is to develop innovation and entrepreneurship. Long story short: in line with EuroQuity, that’s why we offered them to create a label and join us. 

The PARP on EuroQuity Label is eager to create a group of high-potential Polish companies with smart business models and looking for series A investment.

This new label will present the growing Polish SME ecosystem and its high-potential startups to private investors all around the world.
Indeed, the PARP on EuroQuity Label has the ambition to identify and promote companies whose development is based on an innovative vision of the market and its problems, a suitable solution supported by a well-defined strategy and led by talented and enthusiastic teams.

Moreover, the PARP support Polish SMEs in their willingness to design, develop and place their innovative products on the global market through various instruments, i.e.:
  • Acceleration Programs,
  • Start-up platforms schemes,
  • Go-Global type of actions.
To find out which startups are part of PARP Label, click here.
For more detailed information about PARP: https://en.parp.gov.pl/


Wednesday, July 1st 2020

We are very pleased to announce you the third e-pitch session we are organising in collaboration with Solar Impulse foundation on July 7th at 17:00 CEST.


Join the Solar Impulse e-pitch session on July 7th at 5:00pm CET
The third E-pitch exclusively for Solar Impulse Labelled Solutions.
Witness 6 of the finest startups pitching to you directly online.
You can register by clicking here

Here is the selection:

Switzerland - Cleantech/New Materials - Healable and sustainable composite material solutions to improve circularity
Spin-off from a Swiss University after 12 years of thorough research in the field of self-healing composites, the startup delivers for the first time an efficient smart and bio-inspired solution for extending the life-time of composite structures. Their patented solution is preimpregnated textiles integrating a typical chemistry and compatible with existing production lines. These new materials enable repeated damage healing, usage as resistant and lightweight materials, easier recycling at the end-of-life. After successful proof-of-concepts, the startup is now setting up 5 engineering projects with clients in the marine and sport industries for summer 2020.
Production scale-up de-risked, 5 applications settlement | TRL: 7 | TAM: €16bn | Next Step: market industrialization | Amount to raise: €1.4m

FRANCE – Agriculture/Sustainable Development – Increasing soil/plant knowledge for better farming practices using low-cost technology
Started in 2016, the company has designed and commercialized a low-cost high-quality system to measure soil and leaf parameters to allow farmers to make informed decisions about their production practices. Commercialized since 2018, 250 systems are currently active in France with new orders coming in.
10 clients/60 users | TRL 9 | TAM 2018 750M€ | Amount to raise: 300K€

SPAIN – Cleantech/Mobility - Using wind power as a complementary propulsion system for the shipping industry
Delivering of an automated wind-assisted propulsion systems that harness renewable energy (wind) as a turn-key solution to all shipowners looking to decrease their fuel-related costs and pollutant emissions, saving up to 30% of the fuel consumption. The patented technology, successfully tested on ground, is in a phase of expansion, with 4 contracts already signed for product deliveries in 2020/21.
4+ patents worldwide | 4 contracts for 2020/21 | TRL: 6 | TAM: €66bn | Next Step: first deliveries for current customers, validation to TRL 9 and starting commercialization | Amount to raise: €5m (€1.5m already committed)

US & India - Cleantech/ Consumer Products/ Healthcare Product - Sustainable Menstruation Product good for body, community and environment.
A UN-recognized, 100 Best Time Invention List sustainable consumer products company. Manufacturing world's first 100% biodegradable and compostable sanitary pads from banana and bamboo tree fibre. Patent pending technology to convert agri-waste fibers into absorbent material. Addressing three challenges; chemical based sanitary pads, lack of access to sanitary pads in rural areas, and plastic waste produced by commercial sanitary pads.
1 Patent Worldwide | TAM: $550M USD market in India (only 18% of women currently have access to sanitary pads); $20.5B USD worldwide | Expansion Plan: Scale-up  and launch in Northern America and Europe| TRL: 9 | Traction: 5+ countries  | Amount to raise: € 2.2 m in equity and € 2.30 m in debt 

FRANCE - Cleantech/Energy – Energy storage solutions with fast ROI, to build an as-a-service energy transition.
Developing affordable HVAC systems with battery storage, to be installed with photovoltaics inself-consumption. Their core product is based on a multi-patented architecture, allowing the reusing of bike batteries. 
Licensing agreement with Stelpro (North America), partnership with Engie and Butagaz to develop as-a-service offer, project with La Poste to reuse batteries from 10 000 rental e-bikes | SeriesB into preparation  | Amount to raise: € 30M in equity and non-dilutive

FRANCE – Cleantech/Energy – Tidal stream Energy
Tidal stream energy is a renewable, clean, and predictable source of energy offered by the ocean. With two field-tested tidal stream turbines, including the first French grid-connected device, the company stands out as a pioneer in this innovative field. Deployed on the seabed and totally immersed underwater, tidal turbines are deployed in arrays and produce sustainable electricity. The technology credo is inherited from the Oil&Gas and maritime sector: simplicity and ruggedness shall guarantee reliability of underwater equipment for continuous power production.
Main customers: utility or project developers | TRL: 7-8 | TAM: 160 GW | Next Step: commercialisation of pilot tidal arrays |2 EPC contract in France and 1 overseas under negotiation | Amount to raise: €5m
 


Tuesday, June 30th 2020
Save the date for the next Belgian e-pitch Session on the 9th of July!

The next Belgian e-pitch session will take place on thursday July 09 at 5 p.m.
These sessions allow selected companies looking for capital to present their growth project.
Each leader will have as usual a maximum of 8 minutes to convince you to follow him. You can submit your questions online just after each presentation. 


The five companies of this session are active in #MedTech and #HealthTech. Together they are looking for €12M

If you would like to attend, register now
 

The selection is as follows:
 
MedTech – Prevention of scars
Therapy device designed to help prevent or improve scars resulting from incisional surgeries– researched, developed and launched. CE Mark and US FDA registrations achieved. First €3M in contract sales signed in 10 countries.  Earned 4 product awards in France, UK, and USA. Complementary product pipeline with IP,  >€60 billion market size. Teamed with Dupont-Dow and UCL-Université catholique de Louvain. Strong and efficient USA-EU experienced management team.   USA subsidiary established and ready for growth.
Seeking funds to fuel sales growth in the USA - our largest market | €2 M lead investor sought to match Noshaq and SRIW.
 
MedTech | Dissection of pathological tissues
Medical device which makes the selective mechanical dissection of pathological tissues possible, without damaging sensitive tissues and organs.
The proof of principle is supported by clinical trials with more than 1,000 patients in open, laparoscopic and endoscopic procedures. Commercial launch in 14 key countries realized in 2019 (open surgery, expanded to include minimally invasive surgery applications) | €4.2M thought, €1.6M already secured.
 
MedTech | Patient specific bone graft for facial reconstruction
A 3D printed bone implant for facial repairing that allows bone reconstruction without taking the bone from the patient. The solution is scalable and can be used around the world. It's already on the market with very good clinical results. The product is supported by key opinion leaders in facial surgery.
Fully controlled process and material validated in term of biocompatibility. ISO 13485 - 2016 accreditation at SGS | €2.3 M sought.
 
MedTech | World’s first inflatable positioning supports...
... a breakthrough in patient care, hygiene and ergonomics in hospitals. Patented technology to position and move patients with compressed air. Our first innovations are for the operating room (e.g neurosurgery) and intensive care units (e.g COVID patients). We design and produce inflatable positioning devices, which enables healthcare workers to position patients quickly and safe without manual power (avoiding work-related musculoskeletal injuries and sick leave). Our solution can save 25% on personnel in surgery rooms and enable 5% more surgeries daily. The optimal positioning “on air” will avoid complications for patient and enable a revolution in surgical procedures.
Best Tech invention award 2019. European Seal of Excellence 2020. CE mark and launched in June 2019. 350.000€ sales in 2020. Sold in 6 European countries. | €1.5M sought, €750k already secured
 
Social Distancing Smart Device
We’ve designed and built a small wearable device making social distancing easy and allowing GDPR proof contact tracing. Our goal is to ensure business continuity for our clients and help companies become ‘future pandemic proof’. The demand for our devices comes from companies with local and global footprint, looking for solutions to avoid costly lockdowns or quarantines and making sure to provide adequate prevention and detection measures for all their stakeholders.
We’ve setup a distribution network and production process. | €1M sought.



Monday, June 29th 2020

On June 23rd, we present the second pitch session within the framework of Horizon 2020 in which six entrepreneurs will showcase their solutions to help fight Covid-19.


Meet six European entrepreneurs tackling the COVID crisis - June 23rd at 05:00 PM CEST
This session is organized in the frame of the Access2EIC programme.
The 6 companies were selected from the most promising projects submited to the European Innovation Council (EIC) that received the Seal of Excellence.

All these entrepreneurs are  looking for funding from 1M€ to 5M€ and they will be pitching for 8 minutes each next Tuesday,  June 23rd, at 05:00 PM CEST.
This is a collaboration between DG RTD from the European Commission, HI Capital, Deloitte, Dealroom, and EuroQuity.
You can register here 

This session is dedicated to diverse industries such as HealthTech, MedTech, finding solution in Diagnostics & Testing, Therapeutics Technology, Pharmaceutical and Healthcare Management,  check the program below.

If your schedule is too busy, you will still be able to watch the recorded session by registering.

Don’t miss it!

Therapeutics Technology
We offer a novel therapy for treating COPD patients, can also be used in the battle against COVID-19. Our product uses patented multi-frequency positive air pressure pulsations to directly re-open airways and also facilitates removal of mucus that can block airways of COPD and COVID patients. Our product is a drug-free device which can be used both prophylactically with COPD patients to improve lung health prior to infection, or to treat the lungs of COVID-19 patients directly during or post-infection. 
We have raised $7.5M to date between private seed investors, Series A and an EU Horizon 2020 Grant. Two successful clinical trials in COPD have already been completed and Pulsehaler is being prepared for CE Mark / FDA submissions. We have 15 issued patents and more pending. | Capital sought: $1.5M (SAFE - Bridge to Series B) to test for Covid19, submit to CE/FDA, and launch production - Israel
 
Diagnostics & Testing
We are a biotech company working in the field of molecular-level detection of trace elements, bacteria, DNA and RNA. We have developed a low-cost, field deployable SARS-CoV-2 RNA test system which completes from swab to result in under 20 minutes (potentially under 10) using technologies from our group of patents . The test is suitable for use in a wide range of non-clinical applications, to get the world safely back to work and avoid a devastating Covid-19 second wave. The market potential is vast, particularly as the technology has wide applications beyond Covid-19.
The test is based on our established technology and requires investment to complete the approvals testing and deploy at scale. | Capital sought: €1M to scale the Covid-19 tests – UK

Diagnostics & Testing

We are building a Point of care testing device (POCT), for infectious disease and cancer diagnosis. it is based on our AI-powered single molecule nucleic acid counting patented technology. it is 20x faster and 40x cheaper than current standard method based on Polymerase Chain Reaction (PCR). The cloud connectivity of our device make real-time tracing and tracking of pandemics like COVID-19 possible.
The amount raised until now is a seed financing of €400K in convertible loan. we have 2 patent families filed, 34 paying customers world wide and sold over €100K our device probes. Several pipeline project is ongoing in pathogen detection, cancer diagnosis, and cell therapy prognosis.| Capital sought: €2M for HuluSCOPE prototyping and clinical validation of Covid19 testing – Germany

Diagnostics & Testing

We are a biotech SME with a dedicated line of product and services for genetics and genomics. Our product is an in vitro diagnostics (IVD) medical device specifically designed and prototyped for a disruption in the way COVID-19 is diagnosed, with results shown in under 30 min. With our device, the current practice is reversed: instead of the patient’s sample traveling to the lab, it is the lab that travels to the patient, pairing with his/her mobile phone. The dedicated point-of-care device has been rapidly developed by our company in response to the COVID-19 pandemic and is currently in the process of obtaining CE-IVD marking. Based on the extensive expertise of our device in DNA synthesis and molecular diagnostic assays, the device implements a fast (targeting <30 min to result) RNA amplification and detection assay using a small, robust, and inexpensive (<100 EUR/unit in production volume >1000 units) hardware and inexpensive consumables (4 EUR/test in production volume for >10000 tests). Accordingly, the goal of lab-on-phone  and the targeted area of fast, cost-effective, and easily deployable diagnostic systems are in perfect alignment with the scope of our product line growth, while aiming for a timely impact in response to the COVID-19 pandemic.
The amount raised until now: 250 k€ from grants | Capital sought: 2 M€ – Portugal

Pharmaceutical
We are developing a platform to inactivate a broad range of viruses and prevent their associated infections from spreading, focusing initially on Covid19 and Influenza.  The compounds already have documented efficacy against H1N1, RSV and HSV2, supporting the potential to develop broad-spectrum antivirals. Further in vivo and clinical studies are required with a high potential for success. The amount raised until now is of $5M secured by the EPFL to focus on Covid19 allowing preliminary results in vitro to be positive | Capital sought: 3M€ - Switzerland

Healthcare Management

We are a leading health technology company in Europe working in more than 50 hospitals and with relevant partnership throughout the world. We developed an advanced IoT process management platform that helps in the planning of the healthcare organisation processes and optimisation of resources in healthcare facilities. The solution can integrate with any HER system in a market of growing dimension and attractiveness for new players. They operate through a SaaS business model with an excellent cost/benefit profile.
The amount raised until now comes from both VC and EU of about €9.9M of equity and grants which has been necessary to develop the product and start building a customer base | Capital sought: 5M€ - Spain

 


Tuesday, June 9th 2020
Save the date for the next Belgian e-pitch Session on the 11th !

Next Belgian e-pitch session will take place on  Thursday June 11th at 5 p.m.

5 companies active in #healthcare IT, #foodtech, #edtech, #mobility app and #labtech are looking for just over € 1,500,000 for their growth.

Curious to know more, attend the EuroQuity epitch Tuesday 11th of June by registering here

The selection is as follows:

Healthcare IT
The startup has developed unique and innovative patient-centred tools enabling a more personalised and participatory medicine. Their tool is used by diagnosed cancer patients to receive personalised information enabling them to take better part in their treatment choice in a Shared Decision-Making environment, as well as further monitor their health status during and after treatment to provide them and their care team with actionable insights. Furthermore, the tool can ease trial participant recruitment through trial Patient Decision Aids with a first screening of admissibility as well as remote monitoring of participants. The tool is envisioned to leverage, inter alia, the power of predictive models to propose individualised information to the patients. The first client is a clinical trial that takes place in multiple European hospitals enabling them to generate early revenues and receive feedback from a first userbase. Interest from UZ Gent, CU St Luc, the Bordet Institute, UMC+ Maastricht and UCSF |€ 200K sought

Edtech | Secondary school digitalized education
According to education figures, secondary school students loose, on average, up to 6 weeks of lessons per school year, due to the lack of teachers. On top of this, teachers/students absenteeism, is not included in the figures. We make a tool that ensures continuity of learning and retains contact between teachers and students on regular basis. To add to this, the current unique crisis brought a new figure to our understanding : 5 to 10% of secondary students disappeared from school radars, due to a lack of equipment and difficulties related to the use of the proposed solutions. Target: all secondary schools and students | € 120k sought 

Foodtech – More innocent then it tastes
Incredibly tasty, sustainably packaged ice desserts with a daring slug of alcohol. What is the sweetness to our success? A mixture of cane sugar and Stevia of course! We also let you enjoy 100% real fruit, sustainable milk and cream from happy pasture cows, and nothing but the finest Belgian chocolate. And that slug of LiQueur? That's for that extra kick that you won't find anywhere else. Cheers! Clients : Delhaize, Spar, Carrefour, Costco France and many more in our pipeline. | € 400k sought

Mobility management Application for businesses
Transform your parking turmoil into a seamless process with ease using our SMART Parking: Put the right vehicle in the right spot at the right moment! With our app, each parking spot is controlled in real-time by its digital signage connected to complementary management tools, allowing dynamic priority allocation and instantaneous use. Cherry on the cake, thanks to the Spatio-temporal control, each spot can switch momentary into parking sharing mode as a way to engage in social responsibilities.  We are now developing a solution dedication to businesses. Target: universities, hotels, residences, companies in Belgium| €300 k sought for development of the business solution

Labtech | To avoid patient's misdiagnostics.
Up to 40% of medical diagnostic tests for respiratory diseases in the laboratory are falsified by a false negative result which delays patient care. The startup developed and provide an unique non-invasive medical device for sampling and sample management solution ensuring sampling of choice with optimal quality stability and traceability from collection to the laboratory. The benefits for the patient is comfort, rapid and precise diagnosis, while that of the laboratory ones are efficiency, reduction of the Risk management and unnecessary costs. 3 patent portfolios are protecting all of our technologies globally. The first laboratory orders are in progress | Scientific partnership in progress with the LHUB-ULB | € 500k sought in seed capital


Tuesday, June 2nd 2020

We are very pleased to announce you the second e-pitch session we are organising in collaboration with Solar Impulse foundation on June 9th at 17:00 CEST.


Join the Solar Impulse e-pitch session on June 9th at 5:00pm CET

The second E-pitch exclusively for Solar Impulse Labelled Solutions.
Witness 6 of the finest startups pitching to you directly online.

You can register by clicking here

Here is the selection: 

 


Cleantech/Water – Water filtration system to provide drinking water for up to 20 000 people
First French start-up in water filtration with social utility accreditation (ESUS), having developed innovative water filtration systems for drinking water access in developing countries for communities from 500 up to 20 000 people.
Our technologies do not require any chemical nor consumable, and our filters stay operational and safe for 10 years. For €0,52 / m3, we can supply the 1.8B people who have no safe drinking water access worldwide.
Main customers: NGO, public authorities, international organizations | TRL: 8 | TAM: €23bn 0.5M€ sought - France
   
Cleantech/Energy – IoT microturbine for data-driven management of gas/water networks
The company is a spin-off of the Italian Institute of Technology and developed a coin-sized microturbine that harvests up to 150W of electricity off-grid from gas pipelines. It recovers otherwise wasted pressurized natural gas energy. It is currently sold to a number of gas utilities in Italy, and was recently pilot-tested in Latin America. The company is H2020 funded and won several innovation awards, and the technology is ATEX certified for operation in hazardous environments with gas presence. A water microturbine is now under development.
5 customers in Italy, including utilities and an international corporation | TRL: 9 (gas) and TRL 7 (water) | TAM (water): €2bn | Next Step: industrialization and commercialization of water microturbine | 0.5M€ sought - Italy

Cleantech/Energy – Turning hydrogen into a fast-moving consumer good
Spin-off from a company with a successful track record turning innovations into global standards: 30 million vehicles already on-the-road. In 2020 we will launch the new hydrogen storage standard with vehicle manufacturers that have adopted our cartridges:  complete range of 2/3/4 wheel vehicles. Universal, adapted to all light mobility markets, zero-pressure, no distribution infrastructure, 100% green, 100% recyclable, rechargeable at home, more competitive than batteries. 
100+ patents worldwide | TRL: 8 | TAM: €30bn | Next Step: industrialization | 20M€ sought - Switzerland

Renewable energy / Renewable gas
Reduce CO2 in energy intensive manufacturing industries by transforming a costly waste issue, e.g. MDF-dust, into high quality process heat or combined heat and power.
Finalist in SET-Awards, winner of EU-China cleantech competition, Winner of BOIS Energie Innovation competition. Concrete project opportunities together with multinational companies in tissue industry (50% national grant secured) and furniture industry. From LOI to agreement stage in several discussions | TRL: 8 | 8-12M€ sought - Sweden

Cleantech/waste treatment – Mycoremediation of complex soil contamination
With about 2.8 million contaminated sites and annual expenditures of €6.5 bn, soil pollution constitutes an important environmental and economic challenge in Europe. Our unique approach relies on an innovative biotechnology platform that converts low-grade green waste into a bioremediation medium. We introduce an efficient, competitive (> 50% cost reduction), impactful (-70%CO2 emissions) new way to treat heavily contaminated soils. Driven by the vision that future generations deserve to thrive on a clean and healthy planet, our mission is to design impactful, circular and economically sound solutions to bring soils back to life.
Strong industrial partnerships | TRL: 6 | TAM: €3,7bn | Next Step: industrialization | 1.5M€ sought in 2020 (0.5k for closing) and a 3M€ Series A in 2021-2022 - Belgium

Cleantech/Agritech – Extracting Value from Carbon
This Carbon removal technology has created a range of widely patented and commercial “Climate positive” processes that realise value across the whole waste inventory. These are now being installed by major organisations to enhance their businesses. We use captured CO2 and waste to trigger significant Carbon retention and ESG premiums. The first of four applications to commercialise the core technology produces high performance “Climate Positive” fertilisers, from low or negative value inputs/feedstocks.
48 patents worldwide; 29 pending | 3 contracts 2020 (with potential for multiple orders) | TRL 9 | TAM €141bn | Next step: Intl expansion | 16M€ sought - UK

> Register here


Tuesday, June 2nd 2020
Join the InvestHorizon e-pitch Session on June the 9th at 5:00pm
Our next InvestHorizon pitch session will be held online on June the 9th at 5:00 PM CEST.
8 HealthTech companies will be presented.
All these Serie A companies are part of the European InvestHorizon acceleration program, and are looking for funds to continue their growth.

Here is the list of the 8 deeptech companies:

Medtech / Cardiovascular 
We develop a stent like implant to correct mitral regurgitation, thus preventing heart failure. This trans vascular device “Mitral Butterfly” will be delivered via a steerable catheter semi-automatically. Unlike many other mitral artificial implantations, the procedure is a simple, one-step performance, to be used by any interventionists in a variety of mitral pathologies. This award winning, proprietary technology with internationally granted patents, has been tested in silico and in chronic animals showing 100% procedural success and durability up to 90 days. | 10M€ sought – Austria

Medtech / Cancer
Detect Lynch syndrome, prevent cancer. Lynch syndrome is the most common hereditary cancer predisposition, but vastly under diagnosed today. We provide easily interpretable and highly accurate results even before cancers develop, enabling preventive and personalized care. CE-marked as IVD MD, validated and launched in domestic market. LOIs signed with leading hospitals across Europe. Accelerated by InvestHorizon and EIT Health. | 5.0M€ sought – Finland

Medtech / Ophtalmology
Intraocular pressure monitoring contact lens system for better glaucoma and ocular hypertension management. Continuous 24-hour IOP monitoring provides vital information to prevent glaucoma, a leading cause of preventable blindness affecting 70 million people globally. SME Instrument Ph-I Champion, Hello Tomorrow Deep Tech Pioneer, Hello Tomorrow Turkey Challenge Runner-up, Doktorclub - Healthcare Initiative – R&D / Innovation Implementation Award | 3.1M€ sought – Turkey

Medtech / Hip & knee
Produces hip and knee implants made of MP-1™ material self-lubricating, no-wear which lasts in the body for 30 Years. Has CE mark. Now in Post Marketing Clinical Study (PMCS) in 4 centers. Task: to improve life quality - enable surgeries in younger patients and reduce suffering. Partner with Enztec - a TOP orthopedic company in NZ. Winner of ORS award (USA), and of IMEACM award (China), MOU signed with several orthopedic companies (Mathys, Symbios, Ceramtec etc.) | 10M€ sought (in stages) – Israel

Biotech  / Cancer
A development stage biotech company focused on novel therapies for the treatment of cancer. We are currently working on an innovative therapy for the treatment of malignant mesothelioma with a unique mechanism of action (RNA targeting
drug) that is currently completing non-regulatory data and advancing up to first-in-man clinical trials. Innovative SME seal from Spanish Ministry | 6.4 M€ sought – Spain

Biotech / Gene therapy
We are developing a pipeline of synthetic genetic therapy treatments - a completely new non-viral therapeutic approach, recently extended to vaccination - that aims to solve the problems that existing gene therapy technologies face. iLab Laureate – Finalist of Tremplin Senat Award – Nominated amongst the top innovative companies in Gene Therapy by MedicalStartups and InsightsCare – Finalist of European Start Smart Global competition - Winner of the Galien-MedStartUp - Winner of the Innovation & Excellence Prize by Corporate Live Wire | 2.5M€ sought – France

Medtech / Anti-bacterial textiles
We are developing a single-step, sono-coating process, utilizing a unique physical phenomena called cavitation. This process eliminates the need for any chemical binders, greatly reducing the required chemicals in the coating process while allowing for a highly homogenized, high- performance coating with maximum dispersion. First coating on the market is antimicrobial, odor safe, sustainable, and durable to harsh industrial laundries. We are currently working to raise the necessary funds in order to scale-up and commercialize and bring their life saving technology to the marketFashion For Good - Plug & Play, Alumnus, Scaling Program, Horizon 2020 SME Program, Strategic partners : Bruckner I 5M€ sought - Israël
 
> Register here



Tuesday, June 2nd 2020

Meet eight high potential companies selected by the European Innovation Agencies - Taftie - on June 16th at 05:00 PM CEST


Join the Taftie High Potential E-Pitch session on June 16th at 05:00 PM CEST
We proudly present the 8th edition of the Taftie High Potential e-pitch session that will be held online on June 16th at 5:00 PM CEST. If the schedule does not fit you, register anyway , so you will still be able to watch the recorded session.   
 
This session will feature companies in biotech/medtech, AI / 3D Xray, AgriTech, looking for tickets from 0.5 to 10M€.

Companies were selected in collaboration with Taftie, the association that gathers all innovation agencies of European countries. This is a unique opportunity to discover from your office high-potential profiles from all over Europe and to ask them questions by registering here.

See you next June 16th at 5:00 PM CEST. If you have any questions, do not hesitate to contact Cristina Chumacero.

Here is the program:

MedTech
Implantable biomaterial scaffold device for the spinal cord repair following traumatic injury. There is no therapeutic option for injuried patients except a lifetime paralysis burden and a huge cost to society. Based on preclinical data in rats, our device has the potential to avoid degenerescence of the injuried spinal cord, allowing strutural tissue repair and functional recovery including locomotion. Technology transfer budget awarded by SATT Lutech in Paris, Preparing a first in man clinical trial starting in 2023 | TRL 6 |  TAM Western countries : $25B | Next step : seed financing| 0.5M€ sought – France

AI / 3D Xray
We close the industrial gap from sample-based to 100% quality inspection. Our AI-based “Accelerated 3D Xray Inspection” is image-based and fully automated for use on the production floor. Our ambition is that our technological breakthrough will become the new Quality 4.0 Inspection standard for Automotive, Medical/Pharma, Additive Manufacturing & Critical assemblies. | TRL: 5-7 | TAM: 3-10B€ | Next Step: market entry and industrialization | 3.0M€ sought – Belgium

Healthcare software
The company is a software-based solution developer for the healthcare industry, to trace treatments, covering from prescription to their administration.  Treatment safety is paramount and a traceability system much like in the food industry to ensure safety is the future for treatments. Best system in the administration control of oncologic patients from Teknon Foundation 2013 - Most innovative system in the preparation and administration of dangerous medicines from the Spanish Hospital Pharma Society 2014 - Unidosis project received “Excellence R&D Project Award” and grant from CDTI, 2018 - Innovative SME from IPYME Innovadora 2019. Cooperation agreements signed with international Pharma companies Bristol Myers and Novartis. | TRL 9 | TAM:9.6T | Next step: commercial acceleration | 6M€ sought – Spain

SaaS / AI / Agri-Tech
Software that uses AI to analyze complex data patterns from aerial imagery (gathered by drones, satellites...) of crops, fields, and forests, in order to extract accurate digital data of value for improving agricultural processes. So far around 2000 users from over 100 countries paid to use our service. We have customers and partners among world-leading industry players and multinational agribusinesses. | TRL 9 | Next step: scaling up and strengthening go-to-market channels, further shortening R&D cycles. | €1.5M sought - Serbia

Health Care / Cardiovascular  
We do patient-specific blood flow simulations for cardiovascular pre-surgical planning. We provide optimal surgical configurations in silico leading improved quality of life, multi-organ function and shorter operation time for the patients and surgical centers. Received CE mark recently as a Class IIa device and 3 international patents - Used over 200 patients globally and seed clinical trial done – A European Research Council, Proof-of-Concept spinoff – Winner of top entrepreneurship awards | TRL: 8 | TAM: $100M | Next Step: service to new clinical centers/markets | 1.0M€ sought – Turkey

Internet of Things / Environment / AgriTech

A set of smart IoT sensors, cloud solution, artificial intelligence, communication tools and devices for beehive environment detection and healing of beehives. Bees are an extremely endangered element of the planet's ecosystem and are a prerequisite for food security. The company already sells its products in 45 countries around the world. Gold Prize at the Slovak exhibition AGRO, 1st place in the Slovak round and 2nd place internationally at the Social Impact Chivas Venture Voting. | TRL 9 | TAM: $ 27B | Next step: business acceleration | 2 M€ sought – Slovakia

Clinical Diagnostic / Point of Care (POC) Testing
With our instrument, rapid identification of bacterial infections such as urinary tract infections (UTI’s) and bacterial co-infections reported with COVID-19 victims becomes possible at POC in less than 30 min. Cumbersome and time consuming microbiological culture tests (3-4 days) become herewith obsolete. Precise and rapid diagnosis at the doctors’ office or hospital ICU is within reach, allowing for proper medication, reducing the risk of antimicrobial resistance (AMR), and saving lives. Finalist of the 2019 Dutch National Icon. Contract for clinical validation and subsequent piloting at GP group practice signed with leading Dutch 1st line microbiology laboratory | TRL : 6 | TAM : $23B | Next Step : Clinical validation| 10 M€ sought – The Netherlands

IOT / Industry 4.0 / Big Data

For investors looking to benefit from a burning global need of optimization and costs cutting in the industry sector: we are solving essential technology challenges of indoor vehicles positioning. We developed and validated our solution together with manufacturing leaders like Toyota, Bridgestone and Opel. It consists of BI software and tracking hardware, which is non-invasive to plant’s infrastructure. Finalist of accelerator programs: Industry Lab II | KPT ScaleUp | Space3AC ScaleUp
TRL: 7-8 | TAM: $9B | Next Step: commercialization | 1.5M€ sought – Poland



 


Monday, May 18th 2020
1 2 3 4 5 » ... 15
 
Stay informed by suscribing to our newsletter